ArticleTranslational psychiatry2025
Decreased diffusivity along the perivascular spaces in bipolar disorder: an MRI-based cross-sectional and Mendelian randomization study.
Article in Translational psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Individualized DTI-ALPS Identifies Phase-Specific Glymphatic Dysfunction in Early-Stage Bipolar Disorder.Biomedicines · 2026Article
- The olfactory-glymphatic syndrome: linking smell dysfunction, cognitive impairment and sleep disturbances in neuropathological disorders.Frontiers in neuroscience · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
The pathophysiology of bipolar disorder (BD) remains unclear. We investigated whether diffusion tensor imaging along perivascular spaces (DTI-ALPS), a putative MRI marker of glymphatic function, is altered in BD and whether this index relates to structural brain changes and clinical status. We recruited 108 patients with first-diagnosed and drug-naïve BD and 54 healthy controls. Participants underwent comprehensive clinical assessments (depression and mania ratings, functional disability, and neurocognition) and multimodal MRI (DTI-ALPS, free water [FW, a putative biomarker of neuroinflammation], FW-corrected mean diffusivity [MD-t], FW-corrected fractional anisotropy [FA-t], cortical thickness). We additionally assessed the causal association between DTI-ALPS and BD susceptibility using bidirectional Mendelian randomization (MR). BD patients exhibited reduced DTI-ALPS indices vs controls (P = 0.004), correlating with functional impairment (Sheehan Scale: P-corrected = 0.048) and executive dysfunction (Stroop Color and Word Test: P-corrected = 0.039). MR confirmed causal effects of lower DTI-ALPS on BD susceptibility (OR = 0.74, P = 0.01) without reverse causation. Lower DTI-ALPS indices were associated with higher FW in the forceps minor and inferior fronto-occipital fasciculus, and lower FA-t values in the forceps minor. Mediation analysis revealed that FW accumulation mediated 12.4% of the impact of alterations reflected by the DTI-ALPS index on executive performance. Together, these results provide convergent cross-sectional and genetic evidence that BD is associated with reduced DTI-ALPS, potentially reflecting impaired glymphatic fluid transport. These DTI-ALPS changes are clinically relevant, relating to disability and executive deficits in BD, and with increased FW, indicative of neuroinflammation, partly mediating this relationship.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.